Variant report

Variant	esv3388082
Chromosome Location	chr20:25175177-25177725
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:622)
CpG islands
(count:978)
Chromatin interactive
region (count:16)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:622 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr20:25176013-25176425	HepG2	liver:	n/a	n/a
2	ATF2	chr20:25176192-25176491	GM12878	blood:	n/a	n/a
3	ATF3	chr20:25175972-25176540	A549	lung:	n/a	chr20:25176044-25176053
4	ATF3	chr20:25175898-25176470	A549	lung:	n/a	chr20:25176044-25176053
5	ATF3	chr20:25176202-25176391	GM12878	blood:	n/a	n/a
6	ATF3	chr20:25176091-25176405	K562	blood:	n/a	n/a
7	ATF3	chr20:25175968-25176619	HepG2	liver:	n/a	chr20:25176044-25176053
8	ATF3	chr20:25176095-25176474	GM12878	blood:	n/a	n/a
9	ATF3	chr20:25176044-25176392	K562	blood:	n/a	chr20:25176044-25176053
10	BACH1	chr20:25175999-25177550	H1-hESC	embryonic stem cell:	n/a	n/a
11	BCL3	chr20:25175885-25176526	A549	lung:	n/a	chr20:25176345-25176354 chr20:25176313-25176326 chr20:25176043-25176052 chr20:25176040-25176049
12	BHLHE40	chr20:25176219-25176411	HepG2	liver:	n/a	n/a
13	BHLHE40	chr20:25175961-25177007	HepG2	liver:	n/a	n/a
14	BHLHE40	chr20:25175995-25176922	GM12878	blood:	n/a	n/a
15	BHLHE40	chr20:25176032-25176867	K562	blood:	n/a	n/a
16	BRCA1	chr20:25176010-25176459	HepG2	liver:	n/a	n/a
17	BRCA1	chr20:25176897-25177213	HepG2	liver:	n/a	n/a
18	CCNT2	chr20:25176096-25176737	K562	blood:	n/a	chr20:25176265-25176274
19	CEBPB	chr20:25176161-25176482	HepG2	liver:	n/a	n/a
20	CEBPB	chr20:25175966-25176457	K562	blood:	n/a	n/a
21	CEBPB	chr20:25176206-25176427	Hela-S3	cervix:	n/a	n/a
22	CEBPB	chr20:25176158-25176388	HepG2	liver:	n/a	n/a
23	CEBPB	chr20:25175816-25176562	A549	lung:	n/a	n/a
24	CEBPD	chr20:25176038-25176530	HepG2	liver:	n/a	n/a
25	CEBPD	chr20:25175921-25176790	HepG2	liver:	n/a	n/a
26	CHD1	chr20:25175823-25177112	IMR90	lung:	n/a	n/a
27	CHD1	chr20:25175990-25176614	GM12878	blood:	n/a	n/a
28	CHD2	chr20:25176202-25176374	H1-hESC	embryonic stem cell:	n/a	n/a
29	CHD2	chr20:25175965-25176641	GM12878	blood:	n/a	n/a
30	CHD2	chr20:25176777-25176868	HepG2	liver:	n/a	n/a
31	CHD2	chr20:25176087-25176745	Hela-S3	cervix:	n/a	n/a
32	CHD2	chr20:25176167-25176408	K562	blood:	n/a	n/a
33	CHD2	chr20:25176007-25176448	HepG2	liver:	n/a	n/a
34	CREB1	chr20:25175861-25177474	HepG2	liver:	n/a	n/a
35	CREB1	chr20:25175835-25176962	A549	lung:	n/a	n/a
36	CREB1	chr20:25176075-25176667	ECC-1	luminal epithelium:	n/a	n/a
37	CREB1	chr20:25176068-25177048	GM12878	blood:	n/a	n/a
38	CREB1	chr20:25176074-25176594	ECC-1	luminal epithelium:	n/a	n/a
39	CREB1	chr20:25177023-25177412	A549	lung:	n/a	n/a
40	CREB1	chr20:25176074-25176639	H1-hESC	embryonic stem cell:	n/a	n/a
41	CREB1	chr20:25175957-25176562	H1-hESC	embryonic stem cell:	n/a	n/a
42	CREB1	chr20:25175734-25177508	HepG2	liver:	n/a	n/a
43	CREB1	chr20:25176060-25176480	A549	lung:	n/a	n/a
44	CREB1	chr20:25175823-25176641	K562	blood:	n/a	n/a
45	CREB1	chr20:25176099-25176597	K562	blood:	n/a	n/a
46	CTCF	chr20:25175920-25176070	HMF	breast:	n/a	n/a
47	CTCF	chr20:25177620-25177770	A549	lung:	n/a	chr20:25177622-25177630 chr20:25177690-25177699
48	CTCF	chr20:25175960-25176110	AoAF	blood vessel:	n/a	n/a
49	CTCF	chr20:25176460-25176610	GM12874	blood:	n/a	n/a
50	CTCF	chr20:25175920-25176070	NHDF-neo	bronchial:	n/a	n/a

(count:978 , 50 per page) page: 1 2 3 4 5 6 7 ... 20

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr20:25177027-25177077	AG04450	lung:	fetal
2	chr20:25175138-25175188	HEK293	kidney:	embryo
3	chr20:25177027-25177077	AG04450	lung:	fetal
4	chr20:25175138-25175188	HEK293	kidney:	embryo
5	chr20:25176157-25176207	RPTEC	kidney:	n/a
6	chr20:25176178-25176228	AG09309	skin:	n/a
7	chr20:25176379-25176429	PFSK-1	brain:	n/a
8	chr20:25176907-25176957	HIPEpiC	eye:	n/a
9	chr20:25177027-25177077	Hela-S3	cervix:	n/a
10	chr20:25176407-25176457	HCF	heart:	n/a
11	chr20:25177027-25177077	H1-hESC	embryonic stem cell:	embryo
12	chr20:25177340-25177390	HUVEC	blood vessel:	n/a
13	chr20:25177340-25177390	AG04450	lung:	fetal
14	chr20:25176149-25176199	HCT-116	colon:	n/a
15	chr20:25177389-25177439	HAEpiC	amniotic membrane:	n/a
16	chr20:25176220-25176270	HCF	heart:	n/a
17	chr20:25176806-25176856	NB4	blood:	n/a
18	chr20:25176806-25176856	GM12878	blood:	n/a
19	chr20:25176806-25176856	AoSMC	blood vessel:	n/a
20	chr20:25176214-25176264	CMK	blood:	n/a
21	chr20:25176214-25176264	IMR90	lung:	fetal
22	chr20:25176806-25176856	SK-N-MC	brain:	n/a
23	chr20:25176437-25176487	CMK	blood:	n/a
24	chr20:25176214-25176264	HAEpiC	amniotic membrane:	n/a
25	chr20:25176127-25176177	HRE	kidney:	n/a
26	chr20:25176178-25176228	AG04449	skin:	fetal
27	chr20:25176379-25176429	HAEpiC	amniotic membrane:	n/a
28	chr20:25176806-25176856	HRCEpiC	kidney:	n/a
29	chr20:25176379-25176429	CMK	blood:	n/a
30	chr20:25176907-25176957	AG10803	skin:	n/a
31	chr20:25176178-25176228	SAEC	small airway:	n/a
32	chr20:25176220-25176270	HMEC	breast:	n/a
33	chr20:25176806-25176856	HL-60	blood:	n/a
34	chr20:25176437-25176487	GM12892	blood:	n/a
35	chr20:25176157-25176207	GM12892	blood:	n/a
36	chr20:25175138-25175188	GM12878	blood:	n/a
37	chr20:25176178-25176228	GM12891	blood:	n/a
38	chr20:25176178-25176228	Jurkat	blood:	n/a
39	chr20:25177389-25177439	HRCEpiC	kidney:	n/a
40	chr20:25176149-25176199	Hepatocyte	liver:	n/a
41	chr20:25176157-25176207	PFSK-1	brain:	n/a
42	chr20:25176178-25176228	CMK	blood:	n/a
43	chr20:25176178-25176228	H1-hESC	embryonic stem cell:	embryo
44	chr20:25176379-25176429	Hela-S3	cervix:	n/a
45	chr20:25176157-25176207	T-47D	breast:	n/a
46	chr20:25176149-25176199	HRE	kidney:	n/a
47	chr20:25176146-25176196	HCF	heart:	n/a
48	chr20:25176146-25176196	RPTEC	kidney:	n/a
49	chr20:25176437-25176487	NH-A	brain:	n/a
50	chr20:25176407-25176457	U87	brain:	n/a

(count:16 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr20:24971936..24974944-chr20:25175039..25178381,3	MCF-7	breast:
2	chr20:25174902..25179249-chr20:25225017..25231959,9	MCF-7	breast:
3	chr20:25176534..25179250-chr20:25179296..25181376,2	MCF-7	breast:
4	chr20:25177563..25180784-chr20:25185797..25188604,4	MCF-7	breast:
5	chr20:24972059..24974449-chr20:25176101..25177683,2	MCF-7	breast:
6	chr20:25173813..25179807-chr20:25203379..25207002,9	MCF-7	breast:
7	chr20:25175979..25179968-chr20:25200206..25203711,4	MCF-7	breast:
8	chr20:25175724..25177464-chr6:157799912..157802892,2	MCF-7	breast:
9	chr20:25174588..25176232-chr20:25268673..25270382,2	MCF-7	breast:
10	chr20:25174010..25179528-chr20:25225802..25231331,13	MCF-7	breast:
11	chr20:25176590..25179411-chr20:25196913..25199010,2	MCF-7	breast:
12	chr20:25175542..25177840-chr20:25370513..25373072,2	MCF-7	breast:
13	chr20:25176141..25177768-chr20:25206257..25208862,2	MCF-7	breast:
14	chr20:25056370..25059250-chr20:25174569..25177571,3	MCF-7	breast:
15	chr10:103577667..103578508-chr20:25176215..25176933,2	NB4	blood:
16	chr20:25177243..25179011-chr20:25246862..25248615,2	K562	blood:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-ABHD12-4	chr20:25177259-25177528	NR_109994
2	lnc-ABHD12-4	chr20:25177259-25177508	NONHSAT079137

No data

Variant related genes	Relation type
ENTPD6	TF binding region
ENTPD6	CpG island
ENSG00000101474	chromatin interactions
ENSG00000100997	chromatin interactions
ENSG00000100987	chromatin interactions
ENSG00000268302	chromatin interactions
ENSG00000100994	chromatin interactions
ENSG00000198408	chromatin interactions
ENSG00000175048	chromatin interactions
ENSG00000197586	chromatin interactions

Extended variants
information (count: 105 )
Associated
traits (count: 57 )

Variant overlapped rSNPs/rCNVs (count:105 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs563803903	chr20:25175302-25175303	Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
2	rs573956695	chr20:25175322-25175323	Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
3	rs542573816	chr20:25175335-25175336	Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
4	rs373997290	chr20:25175361-25175362	Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
5	rs528786612	chr20:25175375-25175376	Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
6	rs548848371	chr20:25175382-25175383	Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
7	rs545279201	chr20:25175387-25175388	Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
8	rs565376142	chr20:25175396-25175397	Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
9	rs376376736	chr20:25175397-25175398	Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
10	rs531130937	chr20:25175409-25175410	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
11	rs550406358	chr20:25175435-25175436	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
12	rs567313536	chr20:25175466-25175467	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
13	rs6132817	chr20:25175474-25175475	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
14	rs546593089	chr20:25175489-25175490	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
15	rs112216396	chr20:25175494-25175495	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
16	rs556199889	chr20:25175524-25175525	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
17	rs538969880	chr20:25175571-25175572	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
18	rs558883957	chr20:25175572-25175573	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Active TSS	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
19	rs571174609	chr20:25175602-25175603	Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
20	rs569005790	chr20:25175622-25175623	Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
21	rs538001008	chr20:25175661-25175662	Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
22	rs557186072	chr20:25175678-25175679	Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
23	rs574050046	chr20:25175722-25175723	Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
24	rs113033735	chr20:25175755-25175756	Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
25	rs552981997	chr20:25175764-25175765	Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
26	rs572889676	chr20:25175781-25175782	Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
27	rs377736693	chr20:25175810-25175811	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
28	rs111561518	chr20:25175815-25175816	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
29	rs535839765	chr20:25175830-25175831	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
30	rs371512423	chr20:25175840-25175841	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
31	rs538941312	chr20:25175874-25175875	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
32	rs565526676	chr20:25175890-25175891	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
33	rs557142950	chr20:25175965-25175966	Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
34	rs4815391	chr20:25176020-25176021	Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	7 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs112974330	chr20:25176043-25176044	Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
36	rs73339007	chr20:25176063-25176064	Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	7 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
37	rs4815392	chr20:25176101-25176102	Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	7 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs367796180	chr20:25176131-25176132	Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Weak transcription	TF binding region CpG island Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
39	rs546703372	chr20:25176163-25176164	Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Weak transcription	TF binding region CpG island Chromatin interactive region	8 gene(s)	Overlapped CNVs	n/a
40	rs113576495	chr20:25176201-25176202	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	8 gene(s)	Overlapped CNVs	n/a
41	rs566514089	chr20:25176211-25176212	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	8 gene(s)	Overlapped CNVs	n/a
42	rs532145034	chr20:25176213-25176214	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	8 gene(s)	Overlapped CNVs	n/a
43	rs369149684	chr20:25176237-25176238	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
44	rs373326983	chr20:25176275-25176276	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
45	rs371566724	chr20:25176282-25176283	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
46	rs8125833	chr20:25176293-25176294	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
47	rs6083773	chr20:25176296-25176297	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
48	rs546446229	chr20:25176312-25176313	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
49	rs569094969	chr20:25176314-25176315	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
50	rs537662828	chr20:25176317-25176318	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:57)

Disease	PMID	Source
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	16272173	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	19627613	CNVD
colon cancer	17210682	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	21080181	CNVD
Thyroid cancer	19087340	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Colorectal cancer	19359472	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Human rectal carcinomas	16397240	CNVD
Olfactory neuroblastoma	18408657	CNVD
Central neurocytomas	17123091	CNVD
Colorectal cancer	16272173	CNVD
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Colorectal cancer	21645411	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Autism	22495311	CNVD
Renal cell carcinoma	18765545	CNVD
Alagille syndrome	17576883	CNVD
Anaplastic large cell lymphoma	18179710	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Cancer	21183584	CNVD
Myxofibrosarcoma	16751306	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Breast cancer	16608533	CNVD
Bladder cancer	21909424	CNVD
Esophageal cancer	21851588	CNVD
Breast cancer	17133270	CNVD
Thrombophilia	17576883	CNVD
Myelofibrosis	22110671	CNVD
Mental retardation	21062444	CNVD
Hepatocellular carcinoma	22174799	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Chordoma	18071362	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	21364760	CNVD
Oral cancer	21386901	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:494 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr20:25168200-25175800	Weak transcription	Placenta Amnion	Placenta Amnion
2	chr20:25168800-25175200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
3	chr20:25169200-25175600	Weak transcription	Fetal Lung	lung
4	chr20:25169400-25175200	Weak transcription	Lung	lung
5	chr20:25169400-25175600	Weak transcription	Gastric	stomach
6	chr20:25171400-25175600	Weak transcription	Rectal Mucosa Donor 29	rectum
7	chr20:25171600-25175200	Weak transcription	Right Ventricle	heart
8	chr20:25171800-25175600	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
9	chr20:25172000-25175200	Weak transcription	Skeletal Muscle Female	skeletal muscle
10	chr20:25172200-25175800	Weak transcription	Psoas Muscle	Psoas
11	chr20:25172600-25175600	Weak transcription	HMEC	breast
12	chr20:25172800-25175600	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
13	chr20:25173000-25175200	Weak transcription	Left Ventricle	heart
14	chr20:25173000-25175400	Weak transcription	Breast Myoepithelial Primary Cells	Breast
15	chr20:25173000-25175400	Weak transcription	Pancreas	Pancrea
16	chr20:25173000-25175600	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
17	chr20:25173000-25175600	Weak transcription	Placenta	Placenta
18	chr20:25173000-25175800	Weak transcription	Right Atrium	heart
19	chr20:25173200-25175800	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
20	chr20:25173200-25176000	Weak transcription	Ovary	ovary
21	chr20:25173400-25175400	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
22	chr20:25174200-25175600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
23	chr20:25174600-25175800	Enhancers	Fetal Thymus	thymus
24	chr20:25175000-25175200	Enhancers	Fetal Brain Female	brain
25	chr20:25175000-25175600	Enhancers	Primary T cells fromperipheralblood	blood
26	chr20:25175000-25175600	Enhancers	Thymus	Thymus
27	chr20:25175000-25175800	Enhancers	Fetal Brain Male	brain
28	chr20:25175000-25175800	Enhancers	Fetal Heart	heart
29	chr20:25175200-25175400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
30	chr20:25175200-25175400	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
31	chr20:25175200-25175400	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin01	Skin
32	chr20:25175200-25175400	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin02	Skin
33	chr20:25175200-25175400	Enhancers	Brain Angular Gyrus	brain
34	chr20:25175200-25175400	Enhancers	HepG2	liver
35	chr20:25175200-25175600	Enhancers	Primary T helper naive cells fromperipheralblood	blood
36	chr20:25175200-25175600	Enhancers	Primary T regulatory cells fromperipheralblood	blood
37	chr20:25175200-25175600	Enhancers	Skeletal Muscle Female	skeletal muscle
38	chr20:25175200-25175600	Enhancers	Dnd41	blood
39	chr20:25175200-25175800	Flanking Active TSS	H1 Derived Mesenchymal Stem Cells	ES cell derived
40	chr20:25175200-25175800	Enhancers	Primary B cells from peripheral blood	blood
41	chr20:25175200-25175800	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
42	chr20:25175200-25175800	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
43	chr20:25175200-25175800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
44	chr20:25175200-25175800	Enhancers	Primary T killer naive cells fromperipheralblood	blood
45	chr20:25175200-25175800	Weak transcription	Aorta	Aorta
46	chr20:25175200-25175800	Enhancers	Left Ventricle	heart
47	chr20:25175200-25175800	Enhancers	Right Ventricle	heart
48	chr20:25175200-25176000	Enhancers	Lung	lung
49	chr20:25175400-25175600	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
50	chr20:25175400-25175600	Enhancers	Primary T helper naive cells from peripheral blood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links